Everand Logo

Welcome to Everand!

  • STAT

    Celgene just lost a crucial drug for its revenue stream after a clinical trial blowup

    Celgene just lost one of the most important drugs in its research pipeline, a treatment for Crohn's disease, to a late-stage clinical trial blowup.
    by Adam Feuerstein Oct 19, 2017 1 minute

    Celgene just lost one of the most important drugs in its research pipeline to a late-stage clinical trial blowup.

    The drug is

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
    The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
    Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
    STAT1 min read
    STAT+: Nuclear Regulatory Commission Advisers Beset By Conflicts Of Interest, Report Finds
    Advisers to the Nuclear Regulatory Commission, a U.S. government agency tasked with ensuring the safe use of radioactive materials, were beset by conflicts of interest, report finds

    Related Books & Audiobooks